Idursulfase
HGT-ELA-038
Approved mab completed
Quick answer
Idursulfase for Hunter Syndrome is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hunter Syndrome
- Phase
- Approved
- Modality
- mab
- Status
- completed